US Patent Issued to OVID THERAPEUTICS on Nov. 11 for "Methods of treating developmental disorders with gaboxadol" (Connecticut Inventor)

ALEXANDRIA, Va., Nov. 11 -- United States Patent no. 12,465,597, issued on Nov. 11, was assigned to OVID THERAPEUTICS INC. (New York).

"Methods of treating developmental disorders with gaboxadol" was invented by Matthew During (Darien, Conn.).

According to the abstract* released by the U.S. Patent & Trademark Office: "Methods of treating developmental disorders such as Angelman syndrome, Fragile X syndrome, Fragile X-associated tremor/ataxia syndrome (FXTAS), Autistic Spectrum Disorder, Autism, Asperger's syndrome, pervasive developmental disorder, Childhood Disintegrative Disorder, Rett syndrome, Lanau-Kleffner Syndrome, Prader-Willi Syndrome, Tardive Dyskinesia, and/or Williams Syndrome with gaboxadol or a pharmaceutically acceptable sa...